Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$37.11 - $50.69 $7.55 Million - $10.3 Million
203,427 New
203,427 $9.8 Million
Q1 2023

May 15, 2023

BUY
$53.43 - $68.12 $17.9 Million - $22.9 Million
335,859 New
335,859 $20.7 Million
Q3 2021

Nov 15, 2021

SELL
$71.29 - $95.99 $6.06 Million - $8.16 Million
-85,000 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$79.62 - $114.85 $6.77 Million - $9.76 Million
85,000 New
85,000 $7.93 Million
Q1 2021

May 17, 2021

SELL
$77.91 - $125.92 $13.6 Million - $22 Million
-175,000 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$60.0 - $87.29 $6 Million - $8.73 Million
100,000 Added 133.33%
175,000 $15.3 Million
Q3 2020

Nov 16, 2020

SELL
$47.53 - $82.76 $10.7 Million - $18.6 Million
-225,000 Reduced 75.0%
75,000 $5.18 Million
Q2 2020

Aug 14, 2020

BUY
$42.51 - $52.46 $12.8 Million - $15.7 Million
300,000 New
300,000 $14.5 Million

Others Institutions Holding NARI

About Inari Medical, Inc.


  • Ticker NARI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 53,389,700
  • Market Cap $4.25B
  • Description
  • Inari Medical, Inc., a medical device company, develops, manufactures, markets, and sells devices for the interventional treatment of venous diseases in the United States. The company provides ClotTriever, a mechanical thrombectomy system, which is designed to core, capture, and remove large clots from large vessels, as well as for treatment of ...
More about NARI
Track This Portfolio

Track Adage Capital Partners Gp, L.L.C. Portfolio

Follow Adage Capital Partners Gp, L.L.C. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Adage Capital Partners Gp, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Adage Capital Partners Gp, L.L.C. with notifications on news.